The content on this site is intended for healthcare professionals only
Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Nivo + chemo vs chemo as first-line treatment for advanced GC/GEJC/EAC
Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan
20 Jan 2022
OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO
Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco Fr...
19 Jan 2022
OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more
Dr John Haanen, Dr Vivek Subbiah, Dr Christian Rolfo, Dr Jessica Hwang, Dr Nagla...
19 Jan 2022
OncoAlert Colloquium Day 4: GI oncology and EONS
Dr Cathy Eng, Dr Yelena Janjigian, Ms Stacy Hurt, Ms Allison Rosen, Dr Mark Lewi...
19 Jan 2022
OncoAlert Colloquium Day 3: Breast cancer
Dr Erika Hamilton, Dr Bhawna Sirohi, Ms Ginny Mason RN, Dr Hope Rugo, Dr Sara To...
19 Jan 2022
OncoAlert Colloquium Day 2: Lung cancer and MASCC
Dr Stephen Liu, Dr Jack West, Dr Sanay Popat, Dr Jarushka Naidoo, Dr Percy Lee, ...
19 Jan 2022
OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology
Dr Toni Choueiri, Dr Andrea Apolo, Dr Neeraj Agarwal, Dr Piet Ost, Dr Sean McBri...
19 Jan 2022
Dihydropyrimidine dehydrogenase polymorphisms knocking on the door
Dr Mauro Daniel Donadio - AC Camargo Cancer Center, Sao Paulo, Brazil
11 Jan 2022
Social distancing and economic crisis in Latin America during the COVID-19 pande...
Prof Richard Sullivan and Prof Bettina Müller
10 Jan 2022
Frontline treatment with single agent pembrolizumab followed by AVD chemotherapy...
Prof Pamela Allen - Emory University School of Medicine, Georgia, USA
22 Dec 2021
SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC
Dr Aditya Bardia - Mass General Cancer Center, Boston, USA
22 Dec 2021
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgr...
Dr Sara Hurvitz - University of California, Los Angeles, USA
21 Dec 2021